Early Access — free while we kick the tires
EdgarHawk

ACKERMANN CHRISTINA

Director

Director
1 filing analyzed · 1 company · Latest 2024-11-07

Companies

Company Buys Sells Direction
Verona Pharma plc VRNA 1 0 Net buying

Activity

November 2024
2024-11-07 Verona Pharma plc VRNA
high
Buy
41,880 shares
$198,386
Significance 6/10

Director Christina Ackermann buys 41,880 shares of VRNA at $4.74 on 2024-11-06; stock now at $38.18, +20.2% in 30 days

Director Christina Ackermann purchased 41,880 shares at $4.74 on 2024-11-06, establishing an initial position of 41,880 shares. The stock has since appreciated to a current price of $38.18, representing substantial gains since the transaction date. Against a backdrop of significant recent momentum (30-day change: +20.2%, 90-day change: +68.8%), this insider purchase reflects director participation in the company at a substantially lower price point than current market valuation. The company reports negative net income of $-43.0M against quarterly revenue of $5.6M and an annual revenue decline of -100.0%, underscoring that this acquisition occurred while the business remains unprofitable and has contracted materially year-over-year. The director's purchase, combined with the stock's recent sharp appreciation, warrants scrutiny regarding the sustainability of the current valuation and the fundamental drivers behind recent price momentum.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access